These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 26316440

  • 1. Nifedipine in Congenital Hyperinsulinism - A Case Report.
    Khawash P, Hussain K, Flanagan SE, Chatterjee S, Basak D.
    J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):151-4. PubMed ID: 26316440
    [Abstract] [Full Text] [Related]

  • 2. A combination of nifedipine and octreotide treatment in an hyperinsulinemic hypoglycemic infant.
    Durmaz E, Flanagan SE, Parlak M, Ellard S, Akcurin S, Bircan I.
    J Clin Res Pediatr Endocrinol; 2014 Jun; 6(2):119-21. PubMed ID: 24932607
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Assessment of Nifedipine Therapy in Hyperinsulinemic Hypoglycemia due to Mutations in the ABCC8 Gene.
    Güemes M, Shah P, Silvera S, Morgan K, Gilbert C, Hinchey L, Hussain K.
    J Clin Endocrinol Metab; 2017 Mar 01; 102(3):822-830. PubMed ID: 27898257
    [Abstract] [Full Text] [Related]

  • 6. Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinism.
    Saint-Martin C, Zhou Q, Martin GM, Vaury C, Leroy G, Arnoux JB, de Lonlay P, Shyng SL, Bellanné-Chantelot C.
    Clin Genet; 2015 May 01; 87(5):448-54. PubMed ID: 24814349
    [Abstract] [Full Text] [Related]

  • 7. Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy.
    Taylor-Miller T, Houghton J, Munyard P, Kumar Y, Puvirajasinghe C, Giri D.
    J Pediatr Endocrinol Metab; 2020 May 26; 33(5):671-674. PubMed ID: 32267248
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A novel mutation in ABCC8 gene in a newborn with congenital hyperinsulinism -a case report.
    Üstün NU, Dilli D, Kundak AA, Okumus N, Erdoğan D, Apaydın S.
    Fetal Pediatr Pathol; 2013 Dec 26; 32(6):412-7. PubMed ID: 23607867
    [Abstract] [Full Text] [Related]

  • 11. Sirolimus in the treatment of three infants with diffuse congenital hyperinsulinism.
    Al-Balwi R, Al-Atawi M, Al-Otaibi A, Babiker O, Al-Mutair A.
    J Pediatr Endocrinol Metab; 2017 Aug 28; 30(9):1013-1017. PubMed ID: 28787272
    [Abstract] [Full Text] [Related]

  • 12. Clinical Management and Gene Mutation Analysis of Children with Congenital Hyperinsulinism in South China.
    Xu A, Cheng J, Sheng H, Wen Z, Lin Y, Zhou Z, Zeng C, Shao Y, Li C, Liu L, Li X.
    J Clin Res Pediatr Endocrinol; 2019 Nov 22; 11(4):400-409. PubMed ID: 31208162
    [Abstract] [Full Text] [Related]

  • 13. Clinical characteristics, outcome, and predictors of neurological sequelae of persistent congenital hyperinsulinism: A single tertiary center experience.
    Laimon W, Aboelenin HM, El Tantawi NT.
    Pediatr Diabetes; 2021 May 22; 22(3):388-399. PubMed ID: 33528087
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Case report: Exceptional transmission of congenital hyperinsulinism from a focal CHI mother to her diffuse CHI dichorionic diamniotic twins.
    Telehuz D, Plesa O, Bouilloud F, Wucher H, De Lonlay P, Bérat CM, Saint-Martin C, Dupuy O, Arnoux JB.
    Front Endocrinol (Lausanne); 2024 May 22; 15():1408003. PubMed ID: 38952388
    [Abstract] [Full Text] [Related]

  • 16. Sirolimus Therapy and Follow-up in a Patient with Severe Congenital Hyperinsulinism Following Subtotal Pancreatectomy.
    Chen Q, Chen Y, Wang X, Yang H, Zhang Y, Liu X, Yan Y, Wei H.
    J Clin Res Pediatr Endocrinol; 2021 Feb 26; 13(1):119-123. PubMed ID: 32482020
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical presentation and treatment response to diazoxide in two siblings with congenital hyperinsulinism as a result of a novel compound heterozygous ABCC8 missense mutation.
    Galcheva S, Iotova V, Ellard S, Flanagan SE, Halvadzhiyan I, Petrova C, Hussain K.
    J Pediatr Endocrinol Metab; 2017 Apr 01; 30(4):471-474. PubMed ID: 28328534
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical characteristics and phenotype-genotype analysis in Turkish patients with congenital hyperinsulinism; predominance of recessive KATP channel mutations.
    Demirbilek H, Arya VB, Ozbek MN, Akinci A, Dogan M, Demirel F, Houghton J, Kaba S, Guzel F, Baran RT, Unal S, Tekkes S, Flanagan SE, Ellard S, Hussain K.
    Eur J Endocrinol; 2014 Jun 01; 170(6):885-92. PubMed ID: 24686051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.